Intuitive Surgical, Inc. (NASDAQ:ISRG)‘s stock had its “outperform” rating restated by investment analysts at Wedbush in a research report issued to clients and investors on Saturday. They currently have a $800.00 target price on the stock. Wedbush’s price objective would indicate a potential upside of 20.35% from the stock’s current price.

A number of other research analysts have also recently commented on the stock. Evercore ISI cut shares of Intuitive Surgical from a “buy” rating to a “hold” rating and set a $690.00 price target on the stock. in a research report on Wednesday, January 4th. Zacks Investment Research cut shares of Intuitive Surgical from a “buy” rating to a “hold” rating in a research report on Wednesday, December 21st. Barclays PLC reiterated an “overweight” rating and set a $760.00 price target (up from $750.00) on shares of Intuitive Surgical in a research report on Friday, October 21st. Canaccord Genuity raised their target price on shares of Intuitive Surgical from $750.00 to $800.00 and gave the stock a “buy” rating in a report on Wednesday, October 19th. Finally, RBC Capital Markets set a $760.00 target price on shares of Intuitive Surgical and gave the stock a “hold” rating in a report on Wednesday, October 19th. One analyst has rated the stock with a sell rating, eight have assigned a hold rating and thirteen have issued a buy rating to the company’s stock. The company has an average rating of “Buy” and an average target price of $731.97.

Analyst Recommendations for Intuitive Surgical (NASDAQ:ISRG)

Intuitive Surgical (NASDAQ:ISRG) opened at 664.71 on Friday. Intuitive Surgical has a 52-week low of $502.01 and a 52-week high of $727.25. The firm has a market cap of $25.76 billion, a P/E ratio of 35.85 and a beta of 0.52. The company’s 50 day moving average is $637.73 and its 200-day moving average is $672.81.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings results on Tuesday, October 18th. The company reported $6.19 EPS for the quarter, beating analysts’ consensus estimates of $5.13 by $1.06. Intuitive Surgical had a net margin of 27.51% and a return on equity of 15.02%. The business had revenue of $682.90 million for the quarter, compared to analysts’ expectations of $650.49 million. During the same period last year, the business earned $5.24 earnings per share. The business’s quarterly revenue was up 15.8% on a year-over-year basis. On average, equities analysts predict that Intuitive Surgical will post $22.20 EPS for the current fiscal year.

ILLEGAL ACTIVITY NOTICE: This piece of content was reported by Watch List News and is the propert of of Watch List News. If you are accessing this piece of content on another site, it was stolen and republished in violation of US & international trademark and copyright law. The original version of this piece of content can be accessed at http://www.watchlistnews.com/intuitive-surgical-inc-isrg-receives-outperform-rating-from-wedbush/1061342.html.

In other Intuitive Surgical news, CEO Gary S. Guthart sold 13,515 shares of the firm’s stock in a transaction on Monday, November 7th. The stock was sold at an average price of $680.68, for a total transaction of $9,199,390.20. Following the completion of the transaction, the chief executive officer now owns 82,880 shares of the company’s stock, valued at $56,414,758.40. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Lonnie M. Smith sold 275 shares of the firm’s stock in a transaction on Thursday, November 17th. The shares were sold at an average price of $646.50, for a total value of $177,787.50. Following the transaction, the director now directly owns 235,890 shares of the company’s stock, valued at approximately $152,502,885. The disclosure for this sale can be found here. 3.10% of the stock is currently owned by corporate insiders.

Institutional investors have recently made changes to their positions in the stock. Gerstein Fisher raised its position in shares of Intuitive Surgical by 0.4% in the third quarter. Gerstein Fisher now owns 1,119 shares of the company’s stock valued at $811,000 after buying an additional 4 shares in the last quarter. Tokio Marine Asset Management Co. Ltd. raised its position in shares of Intuitive Surgical by 0.5% in the second quarter. Tokio Marine Asset Management Co. Ltd. now owns 1,198 shares of the company’s stock valued at $792,000 after buying an additional 6 shares in the last quarter. Cleararc Capital Inc. raised its position in shares of Intuitive Surgical by 0.7% in the second quarter. Cleararc Capital Inc. now owns 917 shares of the company’s stock valued at $607,000 after buying an additional 6 shares in the last quarter. Atria Investments LLC raised its position in shares of Intuitive Surgical by 1.3% in the third quarter. Atria Investments LLC now owns 462 shares of the company’s stock valued at $335,000 after buying an additional 6 shares in the last quarter. Finally, Rothschild Asset Management Inc. raised its position in shares of Intuitive Surgical by 1.1% in the third quarter. Rothschild Asset Management Inc. now owns 847 shares of the company’s stock valued at $614,000 after buying an additional 9 shares in the last quarter. 90.53% of the stock is owned by institutional investors and hedge funds.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc (Intuitive) designs, manufactures and markets da Vinci Surgical Systems, and related instruments and accessories. The Company’s da Vinci Surgical System consists of a surgeon’s console, a patient-side cart and a vision system. The da Vinci Surgical System translates a surgeon’s hand movements, which are performed on instrument controls at a console, into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.

5 Day Chart for NASDAQ:ISRG

Receive News & Ratings for Intuitive Surgical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.